These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The emergence and ongoing convergent evolution of the N501Y lineages coincides with a major global shift in the SARS-CoV-2 selective landscape. Martin DP; Weaver S; Tegally H; San EJ; Shank SD; Wilkinson E; Lucaci AG; Giandhari J; Naidoo S; Pillay Y; Singh L; Lessells RJ; ; ; Gupta RK; Wertheim JO; Nekturenko A; Murrell B; Harkins GW; Lemey P; MacLean OA; Robertson DL; de Oliveira T; Kosakovsky Pond SL medRxiv; 2021 Jul; ():. PubMed ID: 33688681 [TBL] [Abstract][Full Text] [Related]
3. Evolution, Mode of Transmission, and Mutational Landscape of Newly Emerging SARS-CoV-2 Variants. Chakraborty C; Sharma AR; Bhattacharya M; Agoramoorthy G; Lee SS mBio; 2021 Aug; 12(4):e0114021. PubMed ID: 34465019 [TBL] [Abstract][Full Text] [Related]
4. COVID-19 CG enables SARS-CoV-2 mutation and lineage tracking by locations and dates of interest. Chen AT; Altschuler K; Zhan SH; Chan YA; Deverman BE Elife; 2021 Feb; 10():. PubMed ID: 33620031 [TBL] [Abstract][Full Text] [Related]
5. Detection of a SARS-CoV-2 variant of concern in South Africa. Tegally H; Wilkinson E; Giovanetti M; Iranzadeh A; Fonseca V; Giandhari J; Doolabh D; Pillay S; San EJ; Msomi N; Mlisana K; von Gottberg A; Walaza S; Allam M; Ismail A; Mohale T; Glass AJ; Engelbrecht S; Van Zyl G; Preiser W; Petruccione F; Sigal A; Hardie D; Marais G; Hsiao NY; Korsman S; Davies MA; Tyers L; Mudau I; York D; Maslo C; Goedhals D; Abrahams S; Laguda-Akingba O; Alisoltani-Dehkordi A; Godzik A; Wibmer CK; Sewell BT; Lourenço J; Alcantara LCJ; Kosakovsky Pond SL; Weaver S; Martin D; Lessells RJ; Bhiman JN; Williamson C; de Oliveira T Nature; 2021 Apr; 592(7854):438-443. PubMed ID: 33690265 [TBL] [Abstract][Full Text] [Related]
6. Spread of Gamma (P.1) Sub-Lineages Carrying Spike Mutations Close to the Furin Cleavage Site and Deletions in the N-Terminal Domain Drives Ongoing Transmission of SARS-CoV-2 in Amazonas, Brazil. Naveca FG; Nascimento V; Souza V; Corado AL; Nascimento F; Silva G; Mejía MC; Brandão MJ; Costa Á; Duarte D; Pessoa K; Jesus M; Gonçalves L; Fernandes C; Mattos T; Abdalla L; Santos JH; Martins A; Chui FM; Val FF; de Melo GC; Xavier MS; Sampaio VS; Mourão MP; Lacerda MV; Batista ÉLR; Magalhães ALÁ; Dábilla N; Pereira LCG; Vinhal F; Miyajima F; Dias FBS; Dos Santos ER; Coêlho D; Ferraz M; Lins R; Wallau GL; Delatorre E; Gräf T; Siqueira MM; Resende PC; Bello G; Microbiol Spectr; 2022 Feb; 10(1):e0236621. PubMed ID: 35196783 [TBL] [Abstract][Full Text] [Related]
7. Evolutionary Tracking of SARS-CoV-2 Genetic Variants Highlights an Intricate Balance of Stabilizing and Destabilizing Mutations. Jacob JJ; Vasudevan K; Pragasam AK; Gunasekaran K; Veeraraghavan B; Mutreja A mBio; 2021 Aug; 12(4):e0118821. PubMed ID: 34281387 [TBL] [Abstract][Full Text] [Related]
8. Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020. Leung K; Shum MH; Leung GM; Lam TT; Wu JT Euro Surveill; 2021 Jan; 26(1):. PubMed ID: 33413740 [TBL] [Abstract][Full Text] [Related]
9. The Mutation Profile of SARS-CoV-2 Is Primarily Shaped by the Host Antiviral Defense. Azgari C; Kilinc Z; Turhan B; Circi D; Adebali O Viruses; 2021 Mar; 13(3):. PubMed ID: 33801257 [TBL] [Abstract][Full Text] [Related]
10. Ongoing global and regional adaptive evolution of SARS-CoV-2. Rochman ND; Wolf YI; Faure G; Mutz P; Zhang F; Koonin EV Proc Natl Acad Sci U S A; 2021 Jul; 118(29):. PubMed ID: 34292871 [TBL] [Abstract][Full Text] [Related]
11. Sequence signatures within the genome of SARS-CoV-2 can be used to predict host source. Rudar J; Kruczkiewicz P; Vernygora O; Golding GB; Hajibabaei M; Lung O Microbiol Spectr; 2024 Apr; 12(4):e0358423. PubMed ID: 38436242 [TBL] [Abstract][Full Text] [Related]
12. Exploring the Interaction between E484K and N501Y Substitutions of SARS-CoV-2 in Shaping the Transmission Advantage of COVID-19 in Brazil: A Modeling Study. Zhao S; Ran J; Han L Am J Trop Med Hyg; 2021 Sep; 105(5):1247-1254. PubMed ID: 34583340 [TBL] [Abstract][Full Text] [Related]
13. Long-Term Evolution of SARS-CoV-2 in an Immunocompromised Patient with Non-Hodgkin Lymphoma. Borges V; Isidro J; Cunha M; Cochicho D; Martins L; Banha L; Figueiredo M; Rebelo L; Trindade MC; Duarte S; Vieira L; Alves MJ; Costa I; Guiomar R; Santos M; Cortê-Real R; Dias A; Póvoas D; Cabo J; Figueiredo C; Manata MJ; Maltez F; Gomes da Silva M; Gomes JP mSphere; 2021 Aug; 6(4):e0024421. PubMed ID: 34319130 [TBL] [Abstract][Full Text] [Related]
14. Evidence of SARS-CoV-2 convergent evolution in immunosuppressed patients treated with antiviral therapies. Feng S; Reid GE; Clark NM; Harrington A; Uprichard SL; Baker SC Virol J; 2024 May; 21(1):105. PubMed ID: 38715113 [TBL] [Abstract][Full Text] [Related]
15. Natural selection in the evolution of SARS-CoV-2 in bats created a generalist virus and highly capable human pathogen. MacLean OA; Lytras S; Weaver S; Singer JB; Boni MF; Lemey P; Kosakovsky Pond SL; Robertson DL PLoS Biol; 2021 Mar; 19(3):e3001115. PubMed ID: 33711012 [TBL] [Abstract][Full Text] [Related]